Literature DB >> 10844723

Mixed effect models of longitudinal Alzheimer's disease data: a cautionary note.

J K Milliken1, S D Edland.   

Abstract

Longitudinal studies of cognitive function in Alzheimer's disease (AD) patients are powerful tools to better understand the biology and natural history of the disease, but the attributes of the studies that make them valuable also pose special challenges to analysts. A fundamental problem is the accurate measure of time at which cognitive decline begins. Investigators typically use the date of AD diagnosis or the date of enrollment in an AD study. If the rate of cognitive decline is non-linear, variables associated with the time of diagnosis or enrollment might artificially be associated with the rate of decline. Unlike the mixed effects models typically used to analyse cognitive decline, summary measure analyses do not directly compare the rate of decline with time since decline began, and, therefore, are less sensitive to biased measures of time of decline. We simulated trajectories of cognitive decline using the multivariate normal random effect model and tested the ability of the two analytic techniques to discriminate between true and spurious associations. Our analyses suggest summary measure models are less likely to detect spurious associations generated by biased measures of time at which decline begins, and more likely to detect true associations concealed by biased time measurement. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 10844723     DOI: 10.1002/(sici)1097-0258(20000615/30)19:11/12<1617::aid-sim450>3.0.co;2-c

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  6 in total

1.  Progression in ALS is not linear but is curvilinear.

Authors:  Paul H Gordon; Bin Cheng; Francois Salachas; Pierre-Francois Pradat; Gaelle Bruneteau; Philippe Corcia; Lucette Lacomblez; Vincent Meininger
Journal:  J Neurol       Date:  2010-06-08       Impact factor: 4.849

2.  Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span.

Authors:  Ge Li; Steven P Millard; Elaine R Peskind; Jing Zhang; Chang-En Yu; James B Leverenz; Cynthia Mayer; Jane S Shofer; Murray A Raskind; Joseph F Quinn; Douglas R Galasko; Thomas J Montine
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

Review 3.  Modeling the time-course of Alzheimer dementia.

Authors:  J W Ashford; F A Schmitt
Journal:  Curr Psychiatry Rep       Date:  2001-02       Impact factor: 5.285

4.  Rate of decline in Alzheimer disease measured by a Dementia Severity Rating Scale.

Authors:  Sharon X Xie; Douglas C Ewbank; Jesse Chittams; Jason H T Karlawish; Steven E Arnold; Christopher M Clark
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

5.  Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer's Disease.

Authors:  Charles F Murchison; Byron C Jaeger; Jeff M Szychowski; Gary R Cutter; Erik D Roberson; Richard E Kennedy
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

6.  Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.

Authors:  Ge Li; Elaine R Peskind; Steven P Millard; Peter Chi; Izabela Sokal; Chang-En Yu; Lynn M Bekris; Murray A Raskind; Douglas R Galasko; Thomas J Montine
Journal:  PLoS One       Date:  2009-05-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.